JLJun Liu

Jun Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jun Liu has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • Min Li

    Shanghai-MOST Key Laboratory of Health and Disease Genomics, NHC Key Lab of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai 200237, China

    2 shared publications
  • Qunying Li

    Chongqing Municipal Center for Disease Control and Prevention, Chongqing Institute of Preventive Medicine, Chongqing, 400707, China

    2 shared publications
  • Weijin Zhou

    Key Laboratory of Reproduction Regulation of NPFPC, SIPPR, IRD, Fudan University, Shanghai, China

    2 shared publications
  • Yanyan Mao

    NHC Key Lab of Reproduction Regulation (Shanghai Institute for Biomedical and Pharmaceutical Technologies), School of Pharmacy, Fudan University, Shanghai, China

    2 shared publications
  • Yunyun Wu

    Chongqing Municipal Center for Disease Control and Prevention, Chongqing Institute of Preventive Medicine, Chongqing, 400707, China

    2 shared publications
  • Zihao Wang

    Chongqing Municipal Center for Disease Control and Prevention, Chongqing Institute of Preventive Medicine, Chongqing, 400707, China

    2 shared publications

Latest Publications

  • Open Access

    Joint effects of PM2.5 components during periconception on offspring congenital heart disease risk in Chongqing, China

    by Yi Li, Xiao Zhang, Jie Zhang, Jun Liu, Linjin Di, Deqiang Mao, Zihao Wang, Yunyun Wu, Qunying Li, Xinzhi Xiang, et al.


  • Open Access

    Maternal Exposure to Ozone and the Risk of Birth Defects: A Time-Stratified Case-Crossover Study in Southwestern China

    by Yi Li, Chunbei Zhou, Jun Liu, Deqiang Mao, Zihao Wang, Qunying Li, Yunyun Wu, Jie Zhang, Qi Zhang

    A few studies have explored the relationship between air pollution exposure and the risk of birth defects; however, the ozone-related (O3) effects on preconception and first-trimester exposures are still unknown. In this time-stratified case-crossover study, conditional logistic regressions were applied to explore the associations between O3 exposure and the risk of birth defects in Chongqing, China, and stratified analyses were constructed to evaluate the modifiable factors. A total of 6601 cases of birth defects were diagnosed, of which 56.16% were male. O3 exposure was associated with an increased risk of birth defects, and the most significant estimates were observed in the first month before pregnancy: a 10 ug/m3 increase of O3 was related to an elevation of 4.2% [95% confidence interval (CI), 3.4–5.1%]. The associations between O3 exposure and congenital malformations and deformations of the musculoskeletal system were statistically significant during almost all exposure periods. Pregnant women with lower education and income, and from rural areas, were more susceptible to O3 exposure, with the strongest odds ratios (ORs) of 1.066 (95%CI, 1.046–1.087), 1.086 (95%CI, 1.034–1.140), and 1.053 (95%CI, 1.034–1.072), respectively. Our findings highlight the health risks of air pollution exposure and raise awareness of pregnant women’s vulnerability and the susceptibility window period.


  • Preconception thyroid‐stimulating hormone levels and adverse pregnancy outcomes

    by Min Li, Yang He, Yanyan Mao, Liu Yang, Liang Chen, Jing Du, Qing Chen, Qianxi Zhu, Jun Liu, Weijin Zhou

    Objective: Evidence for the association between subclinical thyroid dysfunction before conception and its pregnancy outcomes is inconsistent. Thus, we evaluated the relationship between preconception thyroid‐stimulating hormone (TSH) levels and adverse pregnancy outcomes.Design: Retrospective cohort study.Methods: A total of 50,217 women without prior thyroid disease who became pregnant within 1 year after undertaking a routine TSH test in the Chongqing Municipality of China (2010–2016) were studied. Restricted cubic spline regression and logistic regression were used to estimate the association between preconception TSH levels and pregnancy outcomes. The main outcomes were individual and composite adverse pregnancy outcomes (CAPOs) comprising pregnancy loss, small for gestational age, large for gestational age, and preterm birth.Results: Incidence of CAPO was 24.19%. Increased preconception TSH level was positively associated with CAPO (odds ratio [OR]/SD: 1.04, 95% confidence interval [CI]: 1.01–1.07) when TSH was ≥2.1 mIU/L, positively associated with pregnancy loss (OR/SD: 1.06, 95% CI: 1.01–1.12) when TSH was <2.1 mIU/L, negatively and positively associated with preterm delivery when TSH levels were 3.0 mIU/L (OR/SD: 1.08, 95% CI: 1.00–1.17), respectively. Women with subclinical hypothyroidism before conception were at a higher risk for CAPO (adjusted odds ratio [aOR]: 1.12, 95% CI: 1.04–1.22), while those with subclinical hyperthyroidism had a higher risk of preterm delivery (aOR: 1.31, 95% CI: 1.01–1.70).Conclusions: Nonlinear associations were indicated between preconception TSH levels and pregnancy outcomes. Subclinical thyroid dysfunction before conception was associated with an increased risk of adverse pregnancy outcomes.


  • Open Access

    Periconceptional Folic Acid Supplementation and the Risk of Spontaneous Abortion among Women Who Prepared to Conceive: Impact of Supplementation Initiation Timing

    by Yan-Yan Mao, Liu Yang, Min Li, Jun Liu, Qian-Xi Zhu, Yang He, Wei-Jin Zhou

    It is unclear whether periconceptional folic acid (FA) supplementation decreases the risk of spontaneous abortion (SA). The impact of supplementation initiation timing has not been ascertained. This cohort study aimed to investigate the association between maternal periconceptional FA supplementation and risk of SA, with due consideration of the supplementation initiation timing. Through the National Free Pre-conception Health Examination Project (NFPHEP), we identified 65,643 pregnancies on FA supplementation in Chongqing, China between 2010 and 2015. After adjusting for covariates, maternal periconceptional FA supplementation was associated with a lower risk of SA (adjusted risk ratio [aRR]: 0.52; 95% confidence interval [CI]: 0.48–0.56). Pregnant women with FA supplementation initiated at least 3 months before conception had a 10% lower risk of SA (aRR: 0.46; 95% CI: 0.42–0.50) than those with FA supplementation initiated 1–2 months before conception (aRR: 0.56; 95% CI: 0.50–0.62) or after conception (aRR: 0.56; 95% CI: 0.51–0.61). These associations might not thoroughly account for FA supplementation, and to some extent our findings confirm the role of the utilization of healthcare in preventing SAs. Women who initiated healthcare, including taking FA earlier during the periconceptional period, could have a lower risk of SA.